Samsung Securities Co.,Ltd. (KRX:016360)
South Korea · Delayed Price · Currency is KRW | Market Cap | 5.97T |
| Revenue (ttm) | 10.34T |
| Net Income (ttm) | 894.31B |
| Shares Out | 89.30M |
| EPS (ttm) | 10,014.61 |
| PE Ratio | 6.68 |
| Forward PE | 6.43 |
| Dividend | 3,500.00 (4.94%) |
| Ex-Dividend Date | Dec 27, 2024 |
| Volume | 553,391 |
| Average Volume | 498,931 |
| Open | 69,200 |
| Previous Close | 70,800 |
| Day's Range | 66,700 - 69,700 |
| 52-Week Range | 39,500 - 80,900 |
| Beta | 0.83 |
| RSI | 37.07 |
| Earnings Date | Aug 11, 2025 |
About Revance Therapeutics
Samsung Securities Co., Ltd. operates as a financial investment company in South Korea and internationally. It offers wealth management, digital asset management, and pension planning services to individual and institutional clients; and consulting services for investing in stocks, bonds, and OTC, as well as merger and acquisition, investment finance, and alternative investment services. The company also provides derivatives trading services, including ELS, DLS, and ETN supply and trading; fixed income, currency, and commodity services; and ins... [Read more]
Financial Performance
In 2024, Samsung Securities's revenue was 10.72 trillion, a decrease of -0.26% compared to the previous year's 10.75 trillion. Earnings were 899.04 billion, an increase of 64.24%.
Financial StatementsNews
Jeff Bezos backs AI chipmaker Tenstorrent
AI hardware startup Tenstorrent raised nearly $700 million in new funding. Tenstorrent raised a $693 million Series D round that values the company at more than $2.6 billion, Bloomberg first reported....